CONMED CFO Todd Garner to step down in March 2026

CONMED Corporation (NYSE: CNMD) announced that Chief Financial Officer Todd Garner will step down from his role effective March 15, 2026. Garner will remain with the medical technology company in an advisory capacity through November 2, 2026, to facilitate the transition.

The company has initiated a search process with an executive search firm to identify Garner's successor. Garner served as CFO for eight years at the Largo, Florida-based company, which provides surgical devices and equipment.

"Todd has been instrumental in strengthening our financial foundation and supporting strategic initiatives that position CONMED for scalable, long-term growth," said Pat Beyer, President and Chief Executive Officer, in a statement.

Garner expressed gratitude for his tenure at CONMED, stating he was "part of such a high-quality, driven team that has dramatically improved the revenue growth and profitability of the company."

CONMED reaffirmed its full-year 2025 consolidated revenue and adjusted earnings per share guidance that was issued on November 5, 2025. The company stated that Garner's departure is not the result of any disagreement regarding the company's financial statements or disclosures.

The announcement was made in a press release statement. CONMED's products are used by surgeons and healthcare professionals in orthopedics, general surgery, gynecology, and thoracic surgery.

You May Also Be Interested In

• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• Peraso secures $25M equity facility with Roth unit
• AXT-Tongmei signs 3-year wafer supply deal with Coherent